APA (7th ed.) Citation

E, M., HM, A., MN, F., & GE, B. (2026). Pharmacological targeting of the senescence-associated secretory phenotype in atherosclerosis: Therapeutic potential of senolytics and senomorphics. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05416-4

Chicago Style (17th ed.) Citation

E, Manni, Al-Kuraishy HM, Fawzy MN, and Batiha GE. "Pharmacological Targeting of the Senescence-associated Secretory Phenotype in Atherosclerosis: Therapeutic Potential of Senolytics and Senomorphics." Naunyn-Schmiedeberg's Archives of Pharmacology 2026. https://doi.org/10.1007/s00210-026-05416-4.

MLA (9th ed.) Citation

E, Manni, et al. "Pharmacological Targeting of the Senescence-associated Secretory Phenotype in Atherosclerosis: Therapeutic Potential of Senolytics and Senomorphics." Naunyn-Schmiedeberg's Archives of Pharmacology, 2026, https://doi.org/10.1007/s00210-026-05416-4.